Juvenile-onset systemic lupus erythematosus and MEFV polymorphism: A case-control association study among Iranian children

Reumatol Clin (Engl Ed). 2023 Jun-Jul;19(6):306-311. doi: 10.1016/j.reumae.2022.07.003.

Abstract

Introduction and objectives: This study is designed to evaluate the potential influences of Mediterranean fever gene (MEFV) gene polymorphism on systemic lupus erythematosus (SLE) in a cohort of juvenile patients. A case-control study was performed on Iranian patients with a mixed ethnicity population.

Patients and methods: Genotypes of 50 juvenile cases, and 85 healthy controls were investigated for identifying M694V and R202Q polymorphism. Genotyping was done utilizing amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) to detect M694V and R202Q mutations, respectively.

Main findings: Our study indicates significant differences in the alleles and genotypes frequencies of MEFV polymorphism between SLE patients and healthy controls (P<0.05). Also, an association was found between renal involvement (50% vs. 8.3%, P=0.000, OR=0.91, 95% CI=0.30-0.278) in juvenile SLE patients and M694V polymorphism incident; But there was no association with other clinical manifestations.

Principal conclusion: We found a significant association between R202Q and M694V polymorphism of the MEFV gene and susceptibility to SLE in the studied population; However, further studies on detailed characterization of these polymorphisms' impacts on the key elements responsible for SLE pathogenesis is of great importance.

Keywords: Case–control study; Estudio de asociación genética; Estudio de casos y controles; Fiebre mediterránea; Genetic association study; Genotyping technique; Lupus eritematoso sistémico; Mediterranean fever; Systemic lupus erythematosus; Técnica de genotipado.

MeSH terms

  • Case-Control Studies
  • Child
  • Genotype
  • Humans
  • Iran
  • Lupus Erythematosus, Systemic* / genetics
  • Lupus Erythematosus, Systemic* / pathology
  • Polymorphism, Genetic*
  • Pyrin / genetics

Substances

  • MEFV protein, human
  • Pyrin